2021 Q4 Form 10-K Financial Statement

#000121390022015536 Filed on March 28, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020
Revenue $12.63M $37.75M
YoY Change 35.93% 24.53%
Cost Of Revenue $8.953M $26.27M
YoY Change 37.28% 22.99%
Gross Profit $3.675M $11.48M
YoY Change 32.76% 28.18%
Gross Profit Margin 29.1% 30.42%
Selling, General & Admin $3.941M $9.994M
YoY Change 20.2% 19.45%
% of Gross Profit 107.23% 87.02%
Research & Development $4.289M
YoY Change
% of Gross Profit 37.34%
Depreciation & Amortization $113.2K $222.1K
YoY Change 30.52% 27.36%
% of Gross Profit 3.08% 1.93%
Operating Expenses $3.941M $9.994M
YoY Change 20.2% 19.45%
Operating Profit -$265.9K $1.491M
YoY Change -47.91% 151.09%
Interest Expense -$70.60K -$49.46K
YoY Change 800.51% -54.26%
% of Operating Profit -3.32%
Other Income/Expense, Net -$844.2K
YoY Change
Pretax Income -$410.6K $1.451M
YoY Change -20.76% 158.44%
Income Tax -$381.0K $422.2K
% Of Pretax Income 29.09%
Net Earnings -$29.65K $1.029M
YoY Change -94.28% 163.99%
Net Earnings / Revenue -0.23% 2.73%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.481K $71.78K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.23M $647.2K
YoY Change 4879.09% -73.45%
Cash & Equivalents $32.23M
Short-Term Investments
Other Short-Term Assets $1.123M $447.5K
YoY Change 151.04% 16.21%
Inventory $5.231M $2.499M
Prepaid Expenses
Receivables $8.983M $5.680M
Other Receivables $0.00 $0.00
Total Short-Term Assets $47.56M $9.273M
YoY Change 412.91% -7.49%
LONG-TERM ASSETS
Property, Plant & Equipment $615.8K $1.808M
YoY Change -65.95% -13.06%
Goodwill
YoY Change
Intangibles $1.929M
YoY Change
Long-Term Investments $231.5M $0.00
YoY Change
Other Assets $0.00 $6.750K
YoY Change -100.0%
Total Long-Term Assets $3.640M $4.031M
YoY Change -9.71% 93.8%
TOTAL ASSETS
Total Short-Term Assets $47.56M $9.273M
Total Long-Term Assets $3.640M $4.031M
Total Assets $51.20M $13.30M
YoY Change 284.85% 9.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.984M $3.268M
YoY Change 52.4% -22.23%
Accrued Expenses $1.147M $1.322M
YoY Change -13.22% 7.19%
Deferred Revenue
YoY Change
Short-Term Debt $162.4K $1.812M
YoY Change -91.04% -15.7%
Long-Term Debt Due $555.9K
YoY Change
Total Short-Term Liabilities $7.831M $8.000M
YoY Change -2.12% -21.58%
LONG-TERM LIABILITIES
Long-Term Debt $976.1K $2.618M
YoY Change -62.71%
Other Long-Term Liabilities $784.7K $1.059M
YoY Change -25.89% -18.77%
Total Long-Term Liabilities $1.761M $3.677M
YoY Change -52.11% 182.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.831M $8.000M
Total Long-Term Liabilities $1.761M $3.677M
Total Liabilities $9.592M $11.68M
YoY Change -17.86% 1.49%
SHAREHOLDERS EQUITY
Retained Earnings $1.862M
YoY Change
Common Stock $1.976K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.61M $1.628M
YoY Change
Total Liabilities & Shareholders Equity $51.20M $13.30M
YoY Change 284.85% 9.92%

Cashflow Statement

Concept 2021 Q4 2020
OPERATING ACTIVITIES
Net Income -$29.65K $1.029M
YoY Change -94.28% 163.99%
Depreciation, Depletion And Amortization $113.2K $222.1K
YoY Change 30.52% 27.36%
Cash From Operating Activities -$3.942M -$1.990M
YoY Change 135.5% -327.99%
INVESTING ACTIVITIES
Capital Expenditures -$74.50K -$176.5K
YoY Change -2.92% 49.7%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$74.50K -$176.5K
YoY Change -2.92% 49.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 35.45M 375.0K
YoY Change 2057.02% -214.88%
NET CHANGE
Cash From Operating Activities -3.942M -1.990M
Cash From Investing Activities -74.50K -176.5K
Cash From Financing Activities 35.45M 375.0K
Net Change In Cash 31.43M -1.791M
YoY Change -29391.0% -518.13%
FREE CASH FLOW
Cash From Operating Activities -$3.942M -$1.990M
Capital Expenditures -$74.50K -$176.5K
Free Cash Flow -$3.867M -$1.813M
YoY Change 142.15% -283.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
CY2021Q2 dei Entity Public Float
EntityPublicFloat
0 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
USD
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
USD
CY2021Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
USD
CY2021Q4 strn Note Payable Line Of Credit
NotePayableLineOfCredit
USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
USD
CY2021Q4 strn Due To Stockholder
DueToStockholder
USD
CY2021Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
USD
CY2020 us-gaap Other Expenses
OtherExpenses
USD
CY2020 strn Ppp Loan Forgiveness
PPPLoanForgiveness
USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
USD
CY2020 strn Reduction In Wildman Earn Out Payment
ReductionInWildmanEarnOutPayment
USD
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
USD
CY2021Q4 strn Current Portion
CurrentPortion
USD
CY2021Q4 strn Long Term Debts
LongTermDebts
USD
CY2021Q4 strn Operating Leases Future Minimum Payment Due In Five Years
OperatingLeasesFutureMinimumPaymentDueInFiveYears
USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2020 us-gaap Restricted Stock Expense
RestrictedStockExpense
USD
CY2020 strn Stock Based Compensation Total
StockBasedCompensationTotal
USD
CY2019Q4 strn Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020 strn Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted
USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2020 strn Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj
USD
CY2020Q4 strn Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
USD
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020 strn Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercisable
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable
USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2021 strn Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited Or Expired And Other Adj
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeitedOrExpiredAndOtherAdj
USD
CY2020Q4 strn Shares Held In Employee Stock Warrants
SharesHeldInEmployeeStockWarrants
shares
CY2020Q4 us-gaap Shares Held In Employee Stock Option Plan Allocated
SharesHeldInEmployeeStockOptionPlanAllocated
shares
CY2020Q4 us-gaap Shares Held In Employee Stock Option Plan Suspense Shares
SharesHeldInEmployeeStockOptionPlanSuspenseShares
shares
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
USD

Files In Submission

Name View Source Status
0001213900-22-015536-index-headers.html Edgar Link pending
0001213900-22-015536-index.html Edgar Link pending
0001213900-22-015536.txt Edgar Link pending
0001213900-22-015536-xbrl.zip Edgar Link pending
ex10-45_001.jpg Edgar Link pending
ex10-46_001.jpg Edgar Link pending
f10k2021ex10-45_stranandcomp.htm Edgar Link pending
f10k2021ex10-46_stranandcomp.htm Edgar Link pending
f10k2021ex31-1_stranandcomp.htm Edgar Link pending
f10k2021ex31-2_stranandcomp.htm Edgar Link pending
f10k2021ex32-1_stranandcomp.htm Edgar Link pending
f10k2021ex32-2_stranandcomp.htm Edgar Link pending
f10k2021ex4-1_stranandcomp.htm Edgar Link pending
f10k2021_stranandcompany.htm Edgar Link pending
f10k2021_stranandcompany_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
strn-20211231.xsd Edgar Link pending
strn-20211231_cal.xml Edgar Link unprocessable
strn-20211231_def.xml Edgar Link unprocessable
strn-20211231_lab.xml Edgar Link unprocessable
strn-20211231_pre.xml Edgar Link unprocessable